Aug 2026
CDC20B Dysregulation: Links to Tumor Prognosis and Immunity.
CDC20B may contribute to tumor progression in a context-dependent manner, with its prognostic impact varying across cancer types, and promoter hypomethylation emerges as a potential epigenetic driver of overexpression.
Hong-Rong Wu, Liang-Li Hong
· Current Medicinal Chemistry · 0 citations